Search for: "Pfizer Inc." Results 1101 - 1120 of 1,505
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
30 Sep 2009, 12:29 am
Wyeth, which is being acquired by Pfizer Inc., has said that it faces more than 9,000 lawsuits over its menopause drugs, along with Pfizer's Pharmacia & Upjohn unit. [read post]
28 Sep 2009, 5:00 pm
Opinion below (7th Circuit) Petition for certiorari Brief in opposition Petitioner's reply Docket: 09-34 Title: Pfizer Inc. v. [read post]
28 Sep 2009, 1:31 am
Bieffe USA, Inc., 35 F. [read post]
28 Sep 2009, 1:31 am
Bieffe USA, Inc., 35 F. [read post]
28 Sep 2009, 1:31 am
Bieffe USA, Inc., 35 F. [read post]
24 Sep 2009, 11:32 am
According to Bloomberg News, the trial judge in Quigley’s bankruptcy trial has ruled that Pfizer Inc. [read post]
22 Sep 2009, 7:28 am by Vanessa Vidal, Esq.
Paulette Morgan, who was a senior corporate counsel at Pfizer Inc., has joined Nixon Peabody as counsel in the firm's global business and transactions practice. [read post]
21 Sep 2009, 11:31 am by Ronda Muir
  Pfizer slashed its outside litigation counsel from 200 to 52. [read post]
16 Sep 2009, 2:00 am
Jack Rovner and Kathy Roe this month launched a new firm called the Health Law Consultancy, betting that greater focus on the area will drive new business"   At plea hearing, judge says he will likely accept Pfizer compliance agreement with HHS "At a hearing on Pfizer Inc.'s $2.3 billion plea agreement with the Department of Justice, a Boston federal judge said he'll probably accept the company's sweeping… [read post]
11 Sep 2009, 1:46 am
Subscription required for online access: [www.law.com] For Pfizer, settlement is a bitter pill "In-house and government lawyers are spinning last week's record-setting health fraud settlement between Pfizer Inc. and the feds in distinctively different ways. [read post]
10 Sep 2009, 8:48 am by Jeff Lowe
Pharmaceutical company Pfizer Inc. will pay $2.3 billion to the federal and state governments over allegations that it illegally marketed several drugs for off-label uses, the New York Times reported Sept. 2. [read post]